Breckenridge Admits Sensipar Generic Violates Amgen Patent
A Delaware federal judge on Thursday approved a settlement in which Breckenridge Pharmaceutical Inc. admitted it infringed Amgen Inc.'s patent for its calcium reducer Sensipar when it asked the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article